Report of the inaugural meeting of the Israeli Society of Gene Therapy (ISGT)
β Scribed by Leslie Ann Mitchell
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 59 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1099-498X
- DOI
- 10.1002/jgm.383
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Cationic liposome-mediated interferon-beta (IFN-b) gene transfer has been found to induce regression of experimental glioma. We performed a pilot clinical trial to evaluate safety and effectiveness of this IFN-b gene therapy in five patients with malignant glioma (glioblastoma multiforme
Severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID) has been considered as one of the best candidate disease for clinical gene therapy. In deed, the first clinical gene therapy trial was performed in 1990-1991 for two patients with ADA-SCID using retrovirus vector (LASN
The 7th Meeting of the European Society of Gene Therapy was held in Munich on November 26Β±28 1999, and was organized by Bernd Ga Γnsbacher and coworkers from the Technical University of Munich. About 600 participants convened to discuss the latest developments in viral and non-viral vector technolog